Publication	Data		Fish	Anatomy
Lelieveld et al., 2022	Fig. 4		gba1zf3252/zf3252 (AB/TL)	liver gpnmb expression increased amount, abnormal liver cholesteryl glycoside increased amount, abnormal liver D-glucosylsphingosine increased amount, abnormal liver glucosylceramide increased amount, abnormal
	Fig. 5		gba1zf3252/zf3252 (AB/TL)	brain apoeb expression increased amount, abnormal brain asah1b expression increased amount, abnormal brain c1qa expression increased amount, abnormal brain c3a.1 expression increased amount, abnormal brain c5ar1 expression increased amount, abnormal brain chia.6 expression increased amount, abnormal brain gpnmb expression increased amount, abnormal brain il1b expression increased amount, abnormal brain tnfb expression increased amount, abnormal brain ab2-map1lc3 labeling increased amount, abnormal brain Ab9-sqstm1 labeling increased amount, abnormal brain autophagy decreased process quality, abnormal brain cholesteryl glycoside increased amount, abnormal brain D-glucosylsphingosine increased amount, abnormal brain glucosylceramide increased amount, abnormal
	Fig. 6		gba1zf3252/zf3252 (AB/TL)	brain mbpa expression decreased amount, abnormal brain sncb expression decreased amount, abnormal brain sncgb expression decreased amount, abnormal brain th expression decreased amount, abnormal periventricular grey zone macrophage increased amount, abnormal periventricular grey zone macrophage increased distribution, abnormal ventricular zone macrophage increased amount, abnormal ventricular zone macrophage increased distribution, abnormal
	Fig. 7		gba1zf3252/zf3252 (AB/TL)	swimming behavior decreased process quality, abnormal trunk curved, abnormal trunk increased curvature, abnormal whole organism decreased length, abnormal whole organism viability, abnormal
Wolińska-Nizioł et al., 2022	Fig. 4		gba1sh391/sh391 (AB/TL)	whole organism swimming behavior decreased process quality, abnormal
Matsui et al., 2021	Fig. 4		gba1nii2/nii2	brain double-stranded DNA binding increased occurrence, abnormal dopaminergic neuron decreased amount, abnormal glucosylceramidase activity decreased process quality, abnormal noradrenergic neuron decreased amount, abnormal regulation of cytoplasmic pattern recognition receptor signaling pathway increased rate, abnormal whole organism caspa expression increased amount, abnormal whole organism cgasa expression increased amount, abnormal whole organism il1b expression increased amount, abnormal whole organism irf3 expression increased amount, abnormal whole organism irf7 expression increased amount, abnormal whole organism nfkbiaa expression increased amount, abnormal whole organism pycard expression increased amount, abnormal whole organism ripk1l expression increased amount, abnormal whole organism sting1 expression increased amount, abnormal
Costa et al., 2020	Fig. 5		gba1sa1621/sa1621 (AB)	vertebral column dvl2 expression decreased amount, abnormal vertebral column dre-mir-221 expression increased amount, abnormal vertebral column mir144 expression decreased amount, abnormal vertebral column mir200a expression increased amount, abnormal vertebral column mir200b expression increased amount, abnormal vertebral column mir34a expression decreased amount, abnormal
Lelieveld et al., 2019	Fig. 2		gba1zf3252/zf3252 (AB/TL)	whole organism gba1 expression decreased amount, abnormal whole organism D-glucosylsphingosine increased amount, abnormal
	Fig. 4		gba1zf3252/zf3252 (AB/TL)	whole organism gba1 expression decreased amount, abnormal whole organism D-glucosylsphingosine increased amount, abnormal
	Fig. 5		gba1zf3252/zf3252 (AB/TL)	whole organism gba1 expression decreased amount, abnormal whole organism D-glucosylsphingosine increased amount, abnormal
Watson et al., 2019	Fig. 1		gba1sh391/sh391	brain cxcl8a expression increased amount, abnormal brain cxcl8b.1 expression increased amount, abnormal brain tnfb expression increased amount, abnormal
	Fig. 3		gba1sh391/sh391	brain cxcl8a expression increased amount, abnormal brain cxcl8b.1 expression increased amount, abnormal brain tnfb expression increased amount, abnormal
	Fig. 4		gba1sh391/sh391	cerebellum microglial cell increased amount, abnormal microglial cell increased accumulation cerebellum, abnormal microglial cell increased accumulation optic tectum, abnormal optic tectum microglial cell increased amount, abnormal
Berg et al., 2016	Fig. 5		w200Tg + MO3-gba1 (AB)	macrophage lysosome accumulation macrophage, abnormal macrophage morphology, abnormal macrophage myeloid leukocyte migration decreased process quality, abnormal macrophage myeloid leukocyte migration process quality, abnormal
	Fig. 6		AB + MO3-gba1	macrophage endocytic recycling decreased occurrence, abnormal
Keatinge et al., 2015	Fig. 1		gba1sh391/sh391 (TL)	glucosylceramidase activity decreased process quality, abnormal
	Fig. 2		gba1sh391/sh391 (TL)	sphingolipid metabolic process disrupted, abnormal
	Fig. 3		gba1sh391/sh391 (TL)	brain chitinase activity increased process quality, abnormal brain hexosaminidase activity increased process quality, abnormal spinal cord curved, abnormal
	Fig. 4		gba1sh391/sh391 (TL)	swimming decreased process quality, abnormal
	Fig. 5		gba1sh391/sh391 (TL)	brain glial cell projection retracted, abnormal brain macrophage increased amount, abnormal brain macrophage morphology, abnormal brain microglial cell circular, abnormal liver macrophage increased amount, abnormal liver macrophage morphology, abnormal macrophage increased accumulation tectal ventricle, abnormal microglial cell increased accumulation brain, abnormal tectal ventricle macrophage increased size, abnormal thymus macrophage increased amount, abnormal thymus macrophage morphology, abnormal
	Fig. 6		gba1sh391/sh391; sh425Tg (TL)	brain mir155 expression increased amount, abnormal microglial cell activation increased occurrence, abnormal microglial cell spherical, abnormal microglial cell vacuole increased amount, abnormal whole organism mir155 expression increased amount, abnormal
	Fig. 7		gba1sh391/sh391 (TL)	brain sncb expression decreased amount, abnormal caudal periventricular hypothalamus dopaminergic neuron decreased amount, abnormal caudal tuberculum dopaminergic neuron decreased amount, abnormal CNS neuron (sensu Vertebrata) inclusion body increased amount, abnormal
	Fig. 8		gba1sh391/sh391 (TL)	brain autophagosome increased amount, abnormal brain cytochrome-c oxidase activity decreased process quality, abnormal brain mitochondrion decreased functionality, abnormal brain ubiquinol-cytochrome-c reductase activity decreased process quality, abnormal
	text only		gba1sh391/sh391 (TL)	whole organism dead, abnormal whole organism decreased life span, abnormal
Zancan et al., 2015	Fig. 1		gba1sa1621/sa1621 ,   zf132Tg + MO2-gba1 ,   WT + MO2-gba1	centrum bone mineralization decreased occurrence, abnormal cranium bone mineralization decreased occurrence, abnormal endochondral ossification decreased occurrence, abnormal intramembranous ossification decreased occurrence, abnormal opercle bone mineralization decreased occurrence, abnormal opercle decreased volume, abnormal osteoblast differentiation decreased occurrence, abnormal trunk curved ventral, abnormal
	Fig. 2		sd2Tg + MO2-gba1 ,   gba1sa1621/sa1621; gz15Tg ,   la2Tg + MO2-gba1 ,   WT + MO2-gba1 ,   gz15Tg + MO2-gba1	definitive hemopoiesis occurrence, abnormal hematopoietic stem cell mislocalised, abnormal hematopoietic system has fewer parts of type nucleate erythrocyte, abnormal hematopoietic system has fewer parts of type thrombocyte, abnormal liver increased size, abnormal spleen increased size, abnormal thrombocyte differentiation decreased occurrence, abnormal
	Fig. 3		WT + MO2-gba1	cellular response to oxidative stress increased occurrence, abnormal
	Fig. 4		ia4Tg + MO2-gba1 ,   gba1sa1621/sa1621; ia4Tg	canonical Wnt signaling pathway decreased occurrence, abnormal
	Fig. 5		WT + MO2-gba1	centrum bone mineralization decreased occurrence, abnormal ceratohyal bone bone mineralization decreased occurrence, abnormal opercle decreased volume, abnormal